Literature DB >> 32861807

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M Fassnacht1, G Assie2, E Baudin3, G Eisenhofer4, C de la Fouchardiere5, H R Haak6, R de Krijger7, F Porpiglia8, M Terzolo9, A Berruti10.   

Abstract

Entities:  

Keywords:  Clinical Practice Guidelines; adrenal cancer; diagnosis; follow-up; treatment

Mesh：

Year:  2020        PMID： 32861807     DOI： 10.1016/j.annonc.2020.08.2099

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  54 in total

Review 1.  KSNM60 in Nuclear Endocrinology: from the Beginning to the Future.

Authors:  Chae Moon Hong; Young Jin Jeong; Hae Won Kim; Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2022-01-24

2.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

Review 3.  Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment.

Authors:  Sara Talvacchio; Matthew A Nazari; Karel Pacak
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

4.  Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer.

Authors:  Elisa Rossini; Mariangela Tamburello; Andrea Abate; Silvia Beretta; Martina Fragni; Manuela Cominelli; Deborah Cosentini; Constanze Hantel; Federica Bono; Salvatore Grisanti; Pietro Luigi Poliani; Guido A M Tiberio; Maurizio Memo; Sandra Sigala; Alfredo Berruti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 5.555

5.  Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma.

Authors:  Deborah Cosentini; Antonella Turla; Ornella Carminati; Salvatore Grisanti; Vittorio Domenico Ferrari; Marta Laganà; Giovanni Rosti; Sandra Sigala; Alfredo Berruti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-22       Impact factor: 5.555

Review 6.  Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.

Authors:  Benjamin Chevalier; Hippolyte Dupuis; Arnaud Jannin; Madleen Lemaitre; Christine Do Cao; Catherine Cardot-Bauters; Stéphanie Espiard; Marie Christine Vantyghem
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-06       Impact factor: 5.555

Review 7.  New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach.

Authors:  Camilo Jimenez; Guofan Xu; Jeena Varghese; Paul H Graham; Matthew T Campbell; Yang Lu
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

8.  Giant androgen-producing adrenocortical carcinoma with atrial flutter: A case report and review of the literature.

Authors:  Mircea-Florin Costache; Raluca-Elena Arhirii; Simona-Juliette Mogos; Corina Lupascu-Ursulescu; Cezara-Ioana Litcanu; Adi-Ionut Ciumanghel; Catalina Cucu; Cristina-Mihaela Ghiciuc; Antoniu-Octavian Petris; Nicolae Danila
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

Review 9.  Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment.

Authors:  Omair A Shariq; Travis J McKenzie
Journal:  Ther Adv Chronic Dis       Date:  2021-07-20       Impact factor: 5.091

Review 10.  Approach to the Patient With Adrenal Incidentaloma.

Authors:  Irina Bancos; Alessandro Prete
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.